Introduction
Hepatocyte Growth Factor (HGF) is a mesenchymal cytokine capable of inducing proliferation, motility (scattering) and branching morphogenesis in epithelial cells (Zarnegar et al., 1995) . These biological responses depend on the interaction of HGF with its receptor, the Met tyrosine kinase. The MET oncogene is overexpressed and ampli®ed in a signi®cant proportion of human tumors . Interestingly, protein overexpression was found to be associated with ampli®cation of the MET gene in only few primary carcinomas, but in a signi®cant proportion of the metastases examined (Di Renzo et al., 1995) . Recently, the mapping of the papillary renal carcinoma-associated gene to a region encompassing the met locus and the subsequent identi®cation of mutations in the MET tyrosine kinase domain of patients aected by this disease, have established a direct genetic connection between activation of this receptor and the development of renal cancers (Schmidt et al., 1997) .
MET was originally identi®ed as a transforming sequence activated by chromosomal rearrangement induced by a chemical carcinogen (Cooper et al., 1984; Park et al., 1986) . The resulting oncogene (TPR-MET) is a hybrid between 5' sequences of TPR, derived from chromosome 1, and 3' sequences of MET, located on chromosome 7. In Tpr-Met, the extracellular domain of Met is replaced by Tpr sequences, which provide two strong dimerization motifs (Rodrigues and Park, 1993) . Dimerization causes constitutive activation of the Met kinase, which acquires transforming, invasive and metastatic potential (Park et al., 1986; Giordano et al., 1997) .
Activation of the Met receptor triggers a number of signaling pathways in target cells. Met signaling is mediated by a multifunctional docking site comprising two tandem arranged phosphotyrosines within the sequence Y 1349 VHVNATY 1356 VNV (Ponzetto et al., 1994) . Upon autophosphorylation, these tyrosines bind and concomitantly activate multiple SH2-containing transducers, including the Grb2/SOS complex, phosphatidylinositol 3-kinase (PI 3-kinase), and phospholipase C-g (PLC-g) (Graziani et al., 1991 (Graziani et al., , 1993 . The multifunctional docking site is an absolute requirement for the receptor's transforming, scattering, invasive and metastatic ability (Weidner et al., 1995; Ponzetto et al., 1996; Giordano et al., 1997) .
Using a two-hybrid approach, the HGF receptor has recently been shown to interact with Gab-1 (Weidner et al., 1996) . Gab1 is an IRS/DOS-like multi-adaptor protein originally cloned according to its ability to bind Grb2 (Holgado-Madruga et al., 1996) . Gab-1 is phosphorylated by both the EGF and the Insulin receptors in a ligand dependent fashion. The primary sequence of Gab1 indicates that it contains a PH domain, a number of consensus binding motifs for SH2-containing molecules and a proline-rich region which includes two optimal binding sites for the SH3 domains of Grb2. In the yeast system, the Gab1/Met interaction is mediated by the proline-rich region of Gab1 (Met Binding Domain) and requires phosphorylation of the Met multifunctional docking site. Overexpression of Gab1 in epithelial cells results in constitutive cell-scattering and branching morphogenesis (Weidner et al., 1996) .
In this work we have investigated the role of Gab1 in Met-mediated transformation and the molecular mechanisms of the Met/Gab1 interaction. We found that Gab1 plays a central role in Met-signaling leading to cellular transformation and that its recruitment requires Grb2. mutant) completely abolishes its transforming potential without aecting the kinase activity (Ponzetto et al., 1994) . To identify molecules implicated in signaling through the Met-multifunctional docking site, we have investigated the substrates that associate with and are phosphorylated by Tpr-Met wt but not by its signalinginactive counterpart Tpr-Met
Results

Gab1 is
. The cDNAs encoding TPR-MET wt and TPR-MET Y1349 ± 1356F were transfected into ®broblasts or epithelial cells and, following cell lysis, the receptor proteins were immunoprecipitated with Met-speci®c antibodies. The proteins associated to the immunoprecipitated TprMet wt and Tpr-Met Y1349 ± 1356F were visualized by kinase assays. These analyses clearly demonstrate that a 110 kDa phosphoprotein is the major tyrosine-phosphorylation substrate of the activated receptor ( Figure  1a ). This molecule binds and is phosphorylated only by the Tpr-Met wt and not by the signaling-inactive mutant (Tpr-Met
) suggesting its possible involvement in receptor signal transduction. The 110 kDa protein is speci®cally phosphorylated by Tpr-Met on tyrosine residues as shown by phosphoaminoacid analysis (Figure 1c) . Recently, it has been shown that the Met receptor interacts with and phosphorylates Gab-1, a 110 kDa IRS-like multiadaptor protein (Weidner et al., 1996) . Therefore, we evaluated the possibility that the 110kDa phosphoprotein could be Gab1. We found that the 110 kDa phosphoprotein is recognized by anti-Gab1 speci®c antibodies (Figure 1b) . We next evaluated the ability of the Met-receptor to induce Gab1 phosphorylation upon ligand stimulation. We found that HGF stimulation of epithelial cells expressing the Met receptor induces rapid and marked phosphorylation of Gab1 on tyrosine residues which results in decreased gel-mobility (Figure 1d ). These experiments show that Gab1 represents the major substrate of both the fulllength and the oncogenic forms of the receptor.
The Gab1 interaction is abrogated by point mutations which selectively uncouple Grb2 from the Met-receptor
In the yeast system, the Met/Gab1 interaction is mediated by the Met Binding Domain (MBD) of Gab1 and requires phosphorylation of the Met multifunctional docking site (Weidner et al., 1996) . We have studied the molecular mechanism of the Met/ Gab1 interaction in mammalian cells using a number of mutants of the receptor multifunctional docking site (Table 1) . We have previously shown that PI3-kinase and PLC-g bind to both tyrosine Y 1349 and Y 1356 and their interaction is abrogated by replacement of the two tyrosines with phenylalanines (Ponzetto et al., 1993 (Ponzetto et al., , 1994 . Grb2 has a strong requirement for an asparagine in the +2 position and speci®cally interacts with Y
1356
. Two other mutants, designed to interfere with the Met/Grb2 interaction, were included in the experiments: to abrogate Grb-2 binding without interfering with the other signaling pathways, asparagine 1358 (which confers Grb2 speci®city to (7) with 120 ng/ml HGF were immunoprecipitated with anti-Gab1 antibodies, subjected to SDS ± PAGE and blotted with anti-phosphotyrosine antibodies. Two major phosphorylated proteins corresponding to the Met receptor (145
Met
) and Gab1 (p110
Gab1
) are present upon HGF stimulation. As a control the same ®lter-blot was probed with anti-Gab1 antibody tyrosine 1356) was substituted with a histidine (TprMet N1358H ); and a mutant with an additional Grb-2 binding was obtained by replacing histidine 1351 with an asparagine (Tpr- Met   H1351N ). In addition, a kinaseinactive mutant (Tpr-Met K1110A ) was also included as a negative control. Wild-type and receptor mutants were transiently expressed in epithelial cells and immunoprecipitated with anti-Met antibodies. The amount of endogenous Gab1 associated with the various mutants was assessed using an anti-Gab1 antibody (Figure 2a ). The amount of associated Grb2 was also evaluated in a similar experiment using anti-Grb2 antibodies ( Figure  2b ). We found that Tpr-Met wt but not the kinaseinactive mutant (Tpr-Met K1110A ) interacts with Gab1 indicating that the association is phosphorylationdependent. Mutation of Y1349 has no eects on Gab1 binding. Binding is abolished when Y1356 alone or in combination with Y1349 is replaced by phenylalanine. Interestingly, the N1358H mutation (Tpr-Met N1358H ), which selectively impairs the Met/ Grb2 interaction, also dramatically aects the Met/ Gab1 interaction (Figure 2a and 2b). Binding is unaected by introduction of a second Grb2 binding site (Tpr- Met   H1351N ). These data show that point mutations which selectively uncouple Grb2 from the receptor also abrogate binding of Gab1 and suggest that Grb2 acts as an adaptor for Gab1 in the Met signaling system.
In the yeast system a proline-rich region of Gab1, referred to as the Met Binding Domain (MBD), is both necessary and sucient to mediate coupling with the Met receptor (Weidner et al., 1996) . We have investigated the speci®city of this interaction in mammalian cells using the MBD domain expressed as a GST fusion protein and the various Tpr-Met mutants transiently transfected in BOSC cells. GST-MBD immobilized on glutathione-Sepharose was used to bind the mutants from cell lysates. The amount of bound receptor was evaluated by Western blotting with anti-Met antibodies. In agreement with our observations using full-size Gab1, we found that the association is phosphorylation-dependent and is abrogated when both tyrosines Y 1349 and Y 1356 are replaced by phenylalanines ( Figure 3) . Furthermore, the N1358H mutation, which selectively impairs the Met/Grb2 association, also reduces the Met/MBD interaction. Binding is slightly increased by introduction of a second Grb2 binding site (Tpr- Met   H1351N ). Interestingly mutation of Y 1349 , which does not aect interaction of Met with full-size Gab1, reduces binding to the isolated MBD region. These data indicate that Met/Gab1 binding is mediated by the MBD region of Gab1 which can potentially interact with both Y 1349 and Y 1356 and that high eciency Met-MBD interaction requires receptor coupling to Grb2. The Grb2-MBD interaction is likely to occur between the Grb2 SH3 domains and the proline-rich motifs (PXXPXR) located within the MBD domain of Gab1.
Peptides blocking either the SH2 or the SH3 domains of Grb2 interfere with Met/Gab1 interaction Grb2 is a modular adaptor protein consisting of an SH2 domain¯anked by two SH3 domains. While the SH2 domain is responsible for binding phosphorylated tyrosines the SH3 domains mediate association with proline-rich regions. Peptides blocking either the SH2 or the SH3 domain of Grb2 were used to directly assess the role of Grb2 in the Met/Gab1 interaction ( Table 2 ). The eects of the peptides on binding of the Met receptor to the isolated MBD domain of Gab1 were initially evaluated using GTL-16 cells. In these cells the Met-receptor is phosphorylated on tyrosine and constitutively binds Grb2 (Ponzetto et al., 1994) . Cell lysates were preincubated with peptides blocking Table 2 ) also reduce binding of the receptor to the MBD region of Gab1. A similar experiment was performed to evaluate the eect of blocking the SH3 domains of Grb2 on the interaction of Met with the MBD domain Gab1. Lysates of cells expressing constitutively phosphorylated HGF receptor were preincubated with a SOS proline-rich peptide which binds the Grb2 SH3 domains. The immobilized recombinant MBD domain of Gab1 was then allowed to associate with the lysates and the ability of the receptor to interact with the MBD region of Gab1 in the presence of the SH3 speci®c peptides was evaluated by Western immunoblotting (Figure 4a ). As for our observation with the SH2 domain, we found that the SH3 domains of Grb2 play a role in the interaction between the Met receptor and the isolated MBD region of Gab1. To prove that the same occurs in intact cells we took advantage of the fact that in GTL16 cells a stable complex exists between the Met-receptor and Gab1 (Figure 4b ). The receptor was immunoprecipitated from cell lysates in the presence of the indicated SH2 or SH3 competing peptides and the amount of associated Gab1 was evaluated by Western immunoblotting (Figure 4b ). In agreement with the data obtained using the isolated MBD region, we found that in vivo the interaction between Met and full size Gab1 can be abolished by peptides blocking either the SH2 or the SH3 domains of Grb2.
The interaction between the isolated Gab1/MBD domain and the Met-multifunctional docking site is mediated by Grb2
In the yeast model the MBD domain of Gab1 appears to bind directly to the Met receptor on phosphorylation of tyrosines 1349 and 1356 in the multifunctional docking site (Weidner et al., 1996) . We used real-time BIAcore-analysis to investigate the mechanism(s) of interaction between the isolated MBD domain and the phosphorylated peptide (IGEHpY   1349   VHVNATpY   1356 VNVK) corresponding to the multifunctional docking site of the Met-receptor. Puri®ed fusion proteins (GST alone, GST-MBD or GST-Grb2) were injected over the immobilized phosphopeptide and association was measured over a range of protein concentrations. While the Grb2-phosphopeptide interaction was readily detected no direct binding was observed with the MBD domain ( Figure 5 ). The MBD region of Gab1 contains two proline rich motifs which match the consensus sequence for binding the SH3 domains of Grb2. Therefore, in the Met signaling system, Grb2 can potentially act as an adaptor for Gab1 by binding the receptor via the SH2 domain and the MBD region of Gab1 through the SH3 domains (Figure 8 ). To test this hypothesis we performed ordered sequential binding experiments. Puri®ed Grb2 was allowed to bind the immobilized Met-phosphopeptide as described above; when the interaction reached the equilibrium, the MBD domain was allowed to interact with the Grb2/Met-phosphopeptide complex. Fig.5 shows that Grb2 directly binds to the Met multifunctional docking site and can sequentially interact with Gab1. Taken together these experiments demonstrate that Gab1 can be indirectly recruited to the receptor via Grb2 (Figure 8 ).
Binding and phosphorylation of Gab1 correlates with the transforming potential of Tpr-Met
Signaling by the Met-receptor is mediated by the multifunctional docking site (Ponzetto et al., 1994) . Mutations within this region dierentially aect the transforming potential of Tpr-Met, the oncogenic (Fixman et al., 1995; Ponzetto et al., 1996) . To assess the role of Gab1 in Met-mediated transformation we have compared the transforming activity of the various docking-site mutants (Figure 6a ) with their ability to recruit and phosphorylate Gab1 (Figure 6b ). Fibroblasts transformed by the cDNA encoding the mutants were lysed and the Tpr-Met proteins were immunoprecipitated with Met-speci®c antibodies. Tpr-Met associated Gab1 was visualized by in vitro kinase assays. We found that the ability to recruit and phosphorylate Gab1 correlates with the transforming potential of the mutants. In particular, wild-type Tpr-Met protein as well as the other transforming mutants associates with, and eciently phosphorylates, Gab1. Conversely, receptor mutants with reduced or absent transforming potential do not interact with Gab1. Moreover, in Tpr-Met transformed cells, Gab1 is constitutively phosphorylated on tyrosine (Figure 7a ). These data indicate that Gab1 operates in Metdownstream pathways leading to cellular transformation.
Gab1 is constitutively tyrosine-phosphorylated in Mettransformed cells and binds SH2-signal transducers
Gab1 contains a number of potential binding sites for the SH2 domains of PI3-kinase, PLC-g and SHPTP2/ Syp. In Met-transformed cells Gab1 is constitutively phosphorylated on tyrosine (Figure 7a ). The interaction of Gab1 with SH2-containing molecules was evaluated in Tpr-Met transformed ®broblasts. Cells were lysed and Gab1 was imunoprecipitated with speci®c antibodies, as a control Gab1 was immunoprecipitated from non transformed ®broblasts. Gab1-associated signal transducers were visualized by Western blotting with speci®c antibodies (Figure 7b ). We found that the amount of p85/PI3-kinase, PLC-g and SHPTP2/Syp bound to Gab1 was signi®cantly increased in Tpr-Met transformed cells with respect to their normal counterpart. Altogether these experiments indicate that in Tpr-Met transformed ®broblasts, Gab1 acts as a docking protein for SH2 containing transducers and suggest that the pathways in which each of these molecules operate may be relevant to Met-mediated transformation. ) and PLC-g, (p140 PLC-g ) were visualized by Western blotting with the indicated antibodies tor-signaling (Ponzetto et al., 1994; Fixman et al., 1995 , Giordano et al., 1997 .
The initial aim of the present study was to identify molecules implicated in signaling through the Metmultifunctional docking site. We found that a 110 kDa protein represents a major phosphorylation substrate of the activated receptor. This molecule binds and is phosphorylated by Tpr-Met wt but not by the signalinginactive mutant (Tpr-Met Y1349 ± 1356F ). It has been shown recently that the Met receptor binds to Gab-1, an IRS/ DOS-like multiadaptor protein (Weidner et al., 1996) . We found that the Tpr-Met-associated 110 kDa phosphoprotein comigrates and is recognized by antiGab1 speci®c antibodies.
The role of Gab1 in Tpr-Met-mediated transformation was evaluated using a series of point mutants in the multifunctional docking that transform ®broblasts with varying eciency. The transforming potential of Tpr-Met mutants correlates with recruitment of Gab1 in vivo indicating that this multiadaptor protein operates in Met downstream pathways leading to cellular transformation. Furthermore, Gab1 is constitutively phosphorylated on tyrosine in Tpr-Met transformed cells and acts as a docking protein for SH2 containing transducers including PI3-kinase, PLC-g and SHPTP2. The pathways in which each of these molecules operate could be relevant to Metmediated transformation. Originally identi®ed as a Grb2 binding molecule, Gab1 was subsequently found to interact with the Met receptor in the yeast twohybrid system (Holgado-Madruga et al., 1996; Weidner et al., 1996) . The primary sequence shows that Gab1 contains a PH domain, a number of potential docking sites for SH2-molecules and a proline-rich region which includes two optimal binding sites for the SH3 domains of Grb2. In the yeast system, the Gab1/Met interaction is mediated by the proline-rich region of Gab1, referred to as the Met Binding Domain (MBD) which binds the multifunctional docking site of the Met receptor in a phosphorylation-dependent fashion. We have investigated the mechanisms of the Met/Gab1 interaction both in vitro and in mammalian cells using mutants of the receptor docking site (Y 1349 VHVNATY 1356 VNV). Binding was phosphorylation dependent and was abolished when both Y 1349 and Y 1356 were replaced with phenylalanines. Interestingly, we found that two mutations (Y1356F and N1358H) which selectively uncouple Grb2 from the receptor (Ponzetto et al., 1996) , also abrogate Gab1 binding in intact cells. Similar results were obtained in in vitro association experiments using the isolated MBD domain of Gab1. Therefore, we conclude that in this cellular system Met-coupling to Gab1 is Grb2 dependent. Grb2 is a modular adaptor protein consisting of an SH2 domain¯anked by two SH3 domains. While the SH2 domain is responsible for binding phosphorylated tyrosines the SH3 domains mediate association with proline-rich regions present in other signalling molecules including SOS, Vav and Abl (Pawson, 1995) .
To de®ne more clearly the role of Grb2 in the Met/ Gab1 interaction we made use of peptides which bind to either the SH2 or the SH3 domains of Grb2. The Met/Gab1 interaction was impaired by peptides interfering with both domains. These experiments indicate that Grb2 may eciently act as an adaptor (Weidner et al., 1996) . We used BIAcore-analysis to measure direct binding of the isolated MBD domain to the above phosporylated sequence. While the direct interaction with Grb2 could be readily detected, no binding was observed with the MBD domain. However, ordered sequential binding experiments showed that the MBD domain eciently associates with the receptor docking site sequence when Grb2 is already bound to Y 1356 . The negative results obtained with the Biacore approach were surprising, given that the MBD domain binds to Met-multifunctional docking in the yeast two-hybrid system (Weidner et al., 1996) . One explanation of this apparent discrepancy could be that additional aminoacids, absent in the peptide used in the BIAcore experiments, are required. Alternatively a longer Gab1 region might be necessary to detect the interaction in vitro. If the MBD domain also binds directly to the two-tyrosine multifunctional docking site, a cooperative`double-hook' model can be proposed for the Met/Gab1 interaction. On one side indirect association occurs via Grb2 which selectively binds Y 1356 , whereas, on the other, the MBD domain of Gab1 might interact directly with Y 1349 (Figure 8 ). The`double-hook' mechanism could confer high speci®city to the interaction and would explain why Gab1 binds preferentially to Met but not to other receptor tyrosine kinases such as Ret and Kit (Weidner et al., 1996) .
It is known that activation of the MET oncogene promotes tumorigenesis in mice and is involved in human cancer. The data presented in this paper further point to a central role for Grb2, including the Figure 8 Cooperative`double-hook' model proposed for the Met/Gab1 interaction. Gab1 can interact both directly and indirectly with the Met multifunctional docking site. On one side indirect association occurs via Grb2 which acts as a Gab1 adaptor by binding tirosine 1356 of Met with the SH2 domain and the proline rich sequences of Gab1 with the SH3 domains. On the other, the MBD domain of Gab1 might interact directly with tyrosine 1349 (Weidner et al., 1996) . The`doublehook' mechanism could confer high speci®city to the interaction and would therefore explain why Gab1 binds selectively to Met but not to other receptor tyrosine kinases such as Ret and Kit recruitment of Gab1, in Met-signaling. Approaches aimed at interfering with the Met-Grb2 interaction are therefore likely to be valuable in the control of the oncogenic properties of the Met receptor.
Materials and methods
Reagents, antibodies and cell culture All reagents used were from Fluka (FlukaChemie AG) and Sigma (Sigma Chemicals Co). Reagents for SDS ± PAGE were from Bio-Rad (Biorad Laboratories). Recombinant HGF was obtained from Baculovirus-infected SF-9 cells (Naldini et al., 1991) . Anti-phosphotyrosine, anti-GAB1 and anti-p85 antibodies were purchased from UBI, anti SHPTP2 antibody was kindly provided by Dr Emma VillaMoruzzi, anti-HGF monoclonal antibodies were obtained in this laboratory (Prat et al., 1991) . BOSC, Fisher Rat and A549 cells were from ATCC. GTL-16 cells were obtained as described (Giordano et al., 1989) . Cultures of mammalian cells were maintained in DMEM or RPMI supplemented with 10% FCS in a humidi®ed atmosphere of 5% CO 2 -air.
Cloning and expression of the Met Binding Domain
Human heart tissue was pulverized in liquid nitrogen and mRNA was prepared with the Guanidine Isothyocianate method (Sambrook et al., 1989) . Poly (A)+ mRNA was isolated with oligo dT-conjugated beads (Dynazyme). One mg of poly (A) + mRNA was used for the synthesis of the ®rst strand of cDNA (reaction mix: 10 mg pd(T) 12 ± 18 , 140 mM potassium chloride, 10 mM magnesium chloride, 1 mM each dNTPs, 4 mM DTT, 25 mM RNAse inhibitor (Promega), 40U Avian reverse transcriptase (Promega) in 50 ml). After 1 h at 378C, the reaction was stopped by boiling for 20 min. Residual RNAs were removed by adding RNAse A (10 mg/ml), 378C, 20 min. PCRs were performed using 25 ml of the cDNA reaction mix as template and the following oligonucleotides as primers: sense primer=5'-AAAATGAATTCCCAATGAATCCCA-ATTCACCACC-3'; antisense primer=5'-TTCTACTCGAG-CTGGCTTGACTTTTCTGTCTGGCTTGAGG TTCC-3'. The underlined residues represent the recognition sequences for the restriction nucleases EcoRI (sense primer) and XhoI (antisense primer). The PCR fragment was digested with EcoRI and XhoI, gel-puri®ed and cloned in the GST-fusion-vector pGEX-4T-2 (Pharmacia). Sequencing of the PCR product (Sequenase, UBI) showed that no mutations were introduced upon ampli®cation. Expression of GST-MBD fusion protein was performed in XL1-blue cells (Stratagene).
Western immunoblotting
After SDS ± PAGE, proteins were transferred to Hybond-ECL membranes (Amersham) by high intensity wet blotting. Filters were probed with the appropriate antibodies and speci®c binding was detected by the Enhanced Chemiluminescence System (ECL, Amersham).
HGF stimulation of epithelial cells
A549 cells were starved in serum-free medium for 24 h, treated with 120 ng/ml HGF and lysed in EB buer (100 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 10% glycerol, 1% Triton X-100) containing protease and phosphatase inhibitors. Immunoprecipitation with antiGab1 or anti-Met antibodies was performed and samples analysed by SDS ± PAGE and Western immunoblotting.
Association experiments
Wild-type or mutant TPR-MET cDNAs were cloned in the pMT2 vector and transiently transfected in BOSC cells using Lipofectin (BRL). After lysis with EB buer, immunoprecipitation with anti-HGF receptor C-terminal antibodies was performed and samples analysed by SDS ± PAGE and Western blotting with anti-Gab1 antibodies. GST-MBD was immobilized on glutathione-Sepharose (Pharmacia) and incubated with lysates of BOSC cells transiently expressing wt or mutant Tpr-Met proteins. After 0.5 M NaCl washing, samples were analysed by SDS ± PAGE and Western blotting with anti-Met antibodies.
Peptide competition experiments
Association experiments were performed in the presence of the indicated concentration of the Met-derived phosphopeptides (pYVHV, pYVNV, pYVHVNATpYVNV) or the SOS-derived peptide (SKGTDEVPVPPPVPPRR) as previously described (Ponzetto et al., 1993) . The SOS peptide was a kindly provided by Dr Ivan Gout.
Biacore-Biosensor analysis
Real-time interaction analysis was performed with a BIAlite-Biosensor (Pharmacia) as previously described Ponzetto et al., 1993) . Puri®ed GST-fusion proteins (MBD or Grb2) were desalted in BIAlite running buer (20 mM Hepes, pH 7.4, 150 mM NaCl, 3.4 mM EDTA, 0.005% Tween20 and 4 mM DTT) and injected over the avidin-immobilized, biotinylated phosphopeptide (GGGGIGEHY*VHVNATY*VNVK, kindly provided by Dr C Battistini, Pharmacia & Upjon Preclinical Research) corresponding to the multifunctional docking site. Association was measured over a range of protein concentrations.
Autokinase assay and phosphoaminoacid analysis
Immunoprecipitation with anti-Met antibodies was performed from lysates of Fisher Rat ®broblasts expressing wt or mutant Tpr-Met proteins. Immunoprecipitates were incubated with Kinase Buer (KB: 50 mM HEPES pH 7.5, 150 mM NaCl, 12.5 mM MgCl 2 ) in the presence of 20 mM ATP including [
32 Pg]ATP for 15 min at 378C. Samples were then analysed by SDS ± PAGE and autoradiography. Bands corresponding to Tpr-Met and Gab1 were cut from the gel and subjected to phosphoaminoacid analysis as described by Cooper et al. (1983) . In the reimmunoprecipitation experiments, after the kinase reaction anti-Met immunoprecipitates were eluted by boiling in the presence of Laemmli Buer without reducing agent (1% SDS, 20 mM Tris-HCl pH 7.4). Samples were then diluted to 0.1% SDS, incubated with anti-Gab1 antibodies and analysed as above.
Focus forming assay
Transfection of the TPR-MET constructs in Fisher rat ®broblasts was carried out using the DNA-calcium phosphate co-precipitation procedure (CellPhect Transfection Kit, Pharmacia). After transfection, cells were split at very low density and kept in DMEM 5% FCS medium. Formation of transformed foci was detected in 2 ± 3 weeks as previously described (Ponzetto et al., 1994) gratefully acknowledged. We thank Dr T Williams for critical reading of the manuscript, A Cignetto for secretarial help and E Wright for editing the manuscript.
